CVS HEALTH Corp

CVS

{{popupValue}}
{{popupSubtitle}}

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
CVS
CIK0000064803
SIC5912
SectorRetail Trade
Industry CategoryRetail
Industry GroupRetail – Drug & Proprietary Stores

Contact

AddressONE CVS DR., WOONSOCKET, RI, 02895
Website cvshealth.com
Phone4017651500
CEOKaren S. Lynch
Employees300,000

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
Revenue$402.07 billion
Pre-Tax Income$2.14 billion
Net Income$1.73 billion
Net Income to Common$1.77 billion
EPS$1.39
View All
Balance Sheet
Cash$8.45 billion
Assets$253.54 billion
Liabilities$178.16 billion
Common Equity$75.21 billion
Liabilities & Equity$253.54 billion
View All
Cash Flow Statement
Calculations
NOPAT$3.77 billion
EBITDA$9.38 billion
Price to Earnings$52.88
Price to Book$1.24
ROE2.29%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Article Link

CVS adds a radical new store concept

CVS is making a comeback with a new store concept. The company is repositioning itself as a health brand. Instead of being the store to quickly stop by for your favorite snacks and pick up some painkillers for your headache while you are there, the company wants to go back to its core business: ...

Article Link

Omnicare Advances Court-Supervised Process While Continuing to Deliver Enhanced Value to Customers

Omnicare, LLC (the "Company" or "Omnicare"), a subsidiary of CVS Health (NYSE: CVS), today announced it has entered into an asset purchase agreement with GenieRx Holdings LLC ("GenieRx"), a joint partnership between private investment firm Milrose Capital LLC and health-care investment and management firm Integro Asset Management LLC, which does business as Integro Healthcare Services. GenieRx will serve as the "stalking horse bidder" in the Company's ongoing court‑supervised sale process.

Article Link

CVS Health (CVS) Under Analyst Spotlight Following Proposed FTC Settlement Related to Insuling Pricing

CVS Health Corporation (NYSE:CVS) is among our picks on the list titled billionaire portfolio: 7 cheap stocks top billionaires are accumulating. As of March 27, 2026, the analyst consensus implies over 35% upside for CVS Health Corporation (NYSE:CVS). More than 80% of analysts maintain bullish ratings on the company despite near-term headwinds. CVS Health Corporation […]

Article Link

CVS Health (CVS) Increases Yet Falls Behind Market: What Investors Need to Know

CVS Health (CVS) closed at $71.82 in the latest trading session, marking a +2.4% move from the prior day.

Article Link